SCHEMBL31268757

SCHEMBL31268757

COc1cccc(Cn2c(-c3ccc(CC(N)=O)cc3Cl)nc3c(OC4(C)CC4)ncnc32)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 5/20 0.38
▸ CYP1A2 P05177 8/20 0.38
▸ CYP3A4 P08684 8/20 0.38
▸ CYP2C9 P11712 8/20 0.38
▸ CYP2C19 P33261 8/20 0.38
▸ USP2 O75604 7/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ LMNA P02545 4/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ PCSK9 Q8NBP7 1/20 0.36
▸ TSHR P16473 3/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ CLK4 Q9HAZ1 1/20 0.36
▸ CCR2 P41597 1/20 0.35
▸ CXCR2 P25025 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269255 0.93 PDE10A (0.38) PLA2G2AUSP2ALDH1A1LMNAHSD17B10
SCHEMBL31268878 0.92 PIK3CD (0.36) PLA2G2AALDH1A1LMNACXCR2ADRA1D
SCHEMBL31269133 0.92 PLA2G2A (0.38) PLA2G2A
SCHEMBL31269290 0.92 PIK3CD (0.37) PLA2G2A
SCHEMBL31268852 0.90 PIK3CD (0.36) —
SCHEMBL31269283 0.90 PIK3CD (0.38) ALDH1A1TSHR
SCHEMBL31269240 0.90 PDE8A (0.35) PLA2G2A
SCHEMBL31269194 0.88 TLR7 (0.36) CCR2ADRA1D
SCHEMBL31268788 0.88 PIK3CD (0.37) CYP1A2CYP3A4CYP2C9CYP2C19USP2
SCHEMBL31268991 0.87 PIK3CD (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback